Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center, Retrospective Study to Evaluate the Clinical Performance of Artificial Intelligence Medical Assisted Diagnostic Software (VeriSee AMD) for Screening of Age-Related Macular Degeneration

NCT05593913 is registered in ClinicalTrials.gov with Acer Medical Inc. as lead sponsor.

NCT NCT05593913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05593913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center, Retrospective Study to Evaluate the Clinical Performance of Artificial Intelligence Medical Assisted Diagnostic Software (VeriSee AMD) for Screening of Age-Related Macular Degeneration
Lead sponsor
Acer Medical Inc.
Phase
Observational
Overall status
Completed
Start date
January 17, 2022
Completion date
August 10, 2022
Enrollment
986 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration, age related, maculopathy, age related